Buzaid AC - Search Results

1

Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10.

Ekmekcioglu S, Okcu MF, Colome-Grimmer MI, Owen-Schaub L, Buzaid AC, Grimm EA. Ekmekcioglu S, et al. Among authors: buzaid ac. Melanoma Res. 1999 Jun;9(3):261-72. doi: 10.1097/00008390-199906000-00008. Melanoma Res. 1999. PMID: 10465582

2

DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.

Buzaid AC, Ali-Osman F, Akande N, Grimm EA, Lee JJ, Bedikian A, Eton O, Papadopoulos N, Plager C, Legha SS, Benjamin RS. Buzaid AC, et al. Melanoma Res. 1998 Apr;8(2):145-8. doi: 10.1097/00008390-199804000-00007. Melanoma Res. 1998. PMID: 9610867 Clinical Trial.

3

Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.

Anderson CM, Buzaid AC, Sussman J, Lee JJ, Ali-Osman F, Braunschweiger PG, Plager C, Bedikian A, Papadopoulos N, Eton O, Legha SS, Grimm EA. Anderson CM, et al. Among authors: buzaid ac. Melanoma Res. 1998 Apr;8(2):149-55. doi: 10.1097/00008390-199804000-00008. Melanoma Res. 1998. PMID: 9610868 Clinical Trial.

4

Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results.

Buzaid AC, Grimm EA, Ali-Osman F, Ring S, Eton O, Papadopoulos NE, Bedikian A, Plager C, Legha SS, Benjamin R. Buzaid AC, et al. Melanoma Res. 1994 Oct;4(5):327-30. doi: 10.1097/00008390-199410000-00010. Melanoma Res. 1994. PMID: 7858418 Clinical Trial.

5

Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1.

Francis GM, Krohn EG, Woods KV, Buzaid AC, Grimm EA. Francis GM, et al. Among authors: buzaid ac. Melanoma Res. 1996 Jun;6(3):191-201. doi: 10.1097/00008390-199606000-00002. Melanoma Res. 1996. PMID: 8819122

6

Interaction of chemotherapy and biological response modifiers in the treatment of melanoma.

Anderson CM, Buzaid AC, Grimm EA. Anderson CM, et al. Among authors: buzaid ac. Cancer Treat Res. 1996;87:357-80. doi: 10.1007/978-1-4613-1267-3_15. Cancer Treat Res. 1996. PMID: 8886461 Review. No abstract available.

7

Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.

Jung FA, Buzaid AC, Ross MI, Woods KV, Lee JJ, Albitar M, Grimm EA. Jung FA, et al. Among authors: buzaid ac. J Clin Oncol. 1997 Aug;15(8):2826-31. doi: 10.1200/JCO.1997.15.8.2826. J Clin Oncol. 1997. PMID: 9256125

8

Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.

Grimm EA, Smid CM, Lee JJ, Tseng CH, Eton O, Buzaid AC. Grimm EA, et al. Among authors: buzaid ac. Clin Cancer Res. 2000 Oct;6(10):3895-903. Clin Cancer Res. 2000. PMID: 11051235 Clinical Trial.

9

Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.

Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, Grimm EA. Ekmekcioglu S, et al. Among authors: buzaid ac. Clin Cancer Res. 2000 Dec;6(12):4768-75. Clin Cancer Res. 2000. PMID: 11156233

10

Detection of melanoma cells in peripheral blood using reverse transcription polymerase chain reaction assay for tyrosinase mRNA.

Jung FA, Buzaid AC, Woods KV, Ross M, Grimm EA. Jung FA, et al. Among authors: buzaid ac. Cancer Surv. 1996;26:251-65. Cancer Surv. 1996. PMID: 8783578 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters